Developer docs
API playgroundTry for free, no card

Search company profiles

Haystack Project

Full company profile

uuid004k3br

Namestring
Haystack Project
Legal namestring
The Haystack Project
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Haystack Project is a 501(c)(3) nonprofit coalition founded in 2016 and headquartered in Washington, DC, that aggregates 140+ ultra-rare disease patient advocacy organizations to collectively address systemic obstacles to patient access. The organization operates a portfolio of advocacy programs rather than a unified product: the Rare Cancer Policy Coalition (RCPC) for rare cancer reimbursement issues, Health Equity in Access to Treatments (HEAT) for disparities in underserved communities, ROPE BRIDGE for payer engagement, and Patient-Oriented Value (POV©) reports that translate patient perspectives into value framework inputs. It runs a Speaker Series featuring FDA, CMS, and industry officials, and conducts direct congressional engagement including hosting roundtables with Senate HELP & Finance Committees and the Congressional Rare Caucus.

The organization's core recent activities center on legislative and regulatory advocacy: it successfully shepherded HEART Act provisions into the 2022 FDA user fee package, filed a Petition for Rulemaking with the FDA in April 2026 calling for a legally binding context-based evidence framework, and drove bipartisan introduction of the PROTECT Rare Act (S.3551) in the Senate. Haystack Project is funded through donations and contributions from individuals, foundations, and industry partners; participation in the coalition is free for qualifying patient advocacy organizations. The organization is staffed by a small team of 6 employees and operates exclusively within the United States.

Short descriptiontext

Haystack Project is a 501(c)(3) nonprofit coalition founded in 2016 that unites 140+ ultra-rare disease patient advocacy organizations to advocate for systemic improvements in healthcare access, FDA regulatory frameworks, payer engagement, and health equity through legislative advocacy, policy initiatives, and educational programming in the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
Markets served

Serves global market

Keyword5 values
rare disease advocacy, patient advocacy coalition, ultra-rare diseases, healthcare policy advocacy, patient access programs
Industry2 codes
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYHLAJAKAN
Global Health Research, Evidence & Technical Assistance Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)
NAICS code2 codes
  • Voluntary Health Organizations813212
  • Individual and Family Services6241
SIC code2 codes
  • Services-Social Services8300
  • Services-Membership Organizations8600
Product category
Rare Disease Patient Advocacy
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Donations and Contributions
TypeGrants Donations
Description

As a 501(c)(3) nonprofit organization, Haystack Project likely relies on tax-deductible donations from individuals, foundations, and industry partners to fund its operations and advocacy programs.

haystackproject.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1Rare Cancer Policy Coalition (RCPC)
Description

A Haystack Project initiative that brings together rare cancer patient organizations focusing on systemic reimbursement barriers and emerging landscape changes impacting new product development and treatment access for rare cancer patients.

haystackproject.org
+3 more records
Core offering1 text field

Haystack Project is a 501(c)(3) non-profit coalition that brings together 140+ ultra-rare disease patient advocacy organizations to address systemic obstacles to patient access. The organization educates policymakers and payers, develops patient-oriented value frameworks, and engages in legislative and regulatory advocacy (including FDA petitions and acts like PROTECT Rare and HEART) to evolve healthcare payment and delivery systems for rare disease therapies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Petition for Rulemaking submitted to FDA calling for context-based evidence framework for rare disease therapies
+2 more records
Product overview1 text field

Haystack Project is a non-profit 501(c)(3) coalition of over 140 ultra-rare patient groups that does not offer a unified software product but rather operates a portfolio of advocacy programs and initiatives. The organization connects rare disease patient advocacy organizations to address systemic patient access obstacles through educational outreach, legislative advocacy (PROTECT Rare Act, HEART Act), payer engagement (ROPE BRIDGE), health equity initiatives (HEAT), patient-oriented value assessment frameworks (POV© Reports), and the Rare Cancer Policy Coalition. Key activities include submitting policy petitions to the FDA (Context-Based Evidence Framework), hosting speaker series, producing white papers and reports, and engaging in coalition-building with stakeholders across the healthcare system.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership6 partners
1Rare Cancer Policy Coalition (RCPC)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

RCPC is a Haystack Project initiative bringing together rare cancer patient organizations. It is the only rare cancer coalition focused specifically on reimbursement, access and value issues. Working within Haystack enables RCPC participants to leverage synergies and common goals to optimize advocacy in disease states where unmet need is high and treatment inadequacies can be catastrophic. National Cancer Institute defines rare cancer as occurring in fewer than 15 out of 100,000 people per year.

haystackproject.org
2Siegel Rare Neuroimmune Association (SRNA)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

SRNA is the first organization to leverage Haystack Project's Health Equity in Access to Treatments (HEAT) initiative. The partnership aims to investigate health equity issues in neuroimmune disorders, understand variability in access and disease burden, identify barriers to diagnosis and treatment especially for underserved populations, and assess representativeness of SRNA's outreach and education efforts.

haystackproject.org
3ROPE BRIDGE Payer Council Partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Haystack Project is launching ROPE BRIDGE, a collaborative bi-directional education effort with payers including Medicare Advantage plans, Medicaid managed care plans, and other community, regional, and national plans. The initiative seeks common ground between payers and patients, creating ongoing dialogue about utilization management approaches, documentation requirements, and medical necessity criteria.

haystackproject.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Haystack Project has engaged extensively with ICER's stakeholder engagement function and secured access to ICER's Analytics and modeling capabilities. Haystack joined ICER's Fair Access Working Group. The organization has spent considerable time educating 80+ rare patient groups about value frameworks and their impact on patient access, and the inadequacy of models used by ICER for extremely rare conditions.

5American Enterprise Institute (AEI)
Strategic tierMinorTypeGTM or Marketing Partner
Description

AEI logo appears on the Speaker Series page, indicating a partnership for educational programming. Nature of partnership appears to involve joint hosting of speaker series events or educational content related to healthcare policy.

haystackproject.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Organization represented in Haystack Project speaker series, indicating ongoing dialogue on rare disease policy issues. Nissa Shaffi, Associate Director of Public Policy, presented at October 2023 speaker series.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Patient Advocate Foundation provides direct case management and access support for patients including those with rare diseases; comparable in patient access mission and payer navigation focus, though service-delivery rather than coalition-based.

TypeDirect peer
Description

Global Genes is a rare disease patient advocacy organization that builds coalitions, educates patients, and advocates for policy; it is directly comparable to Haystack in mission and constituency, though with broader (rather than ultra-rare) disease coverage.

TypeDirect peer
Description

National Patient Advocate Foundation provides case management, policy advocacy, and financial assistance for patients with chronic and rare diseases; it is comparable to Haystack's patient advocacy and payer engagement focus.

4FasterCures (Milken Institute)
TypeOthers
Description

FasterCures is a policy and advocacy program of the Milken Institute focused on accelerating medical research and patient access; it is adjacent to Haystack in the rare disease policy ecosystem but operates from a think-tank rather than coalition structure.

5Rare Disease Legislative Advocates (RDLA)
TypeDirect peer
Description

RDLA coordinates Congressional advocacy for the rare disease community, including Rare Disease Week on Capitol Hill—an activity that directly overlaps with Haystack's Congressional engagement and Protect Rare Act advocacy.

TypeBroad incumbent
Description

NORD is the largest US rare disease patient advocacy organization representing 300+ disease-specific member organizations; it is a broad incumbent in the same space as Haystack, with deeper resources but broader (rather than ultra-rare-focused) policy agenda.

TypeBroad incumbent
Description

National Health Council is a membership organization for patient advocacy groups that engages on value assessment, payer access, and FDA policy; comparable to Haystack as an umbrella advocacy coalition, though broader than ultra-rare.

TypeDirect peer
Description

EveryLife Foundation is a rare disease public policy advocacy organization that drives federal and state policy on newborn screening, access to therapies, and FDA engagement—directly comparable to Haystack's legislative and regulatory advocacy mission.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Haystack Project

Rare Disease Patient Advocacyhaystackproject.org

Haystack Project is a 501(c)(3) nonprofit coalition founded in 2016 that unites 140+ ultra-rare disease patient advocacy organizations to advocate for systemic improvements in healthcare access, FDA regulatory frameworks, payer engagement, and health equity through legislative advocacy, policy initiatives, and educational programming in the United States.

What Haystack Project does

Haystack Project is a 501(c)(3) nonprofit coalition founded in 2016 and headquartered in Washington, DC, that aggregates 140+ ultra-rare disease patient advocacy organizations to collectively address systemic obstacles to patient access. The organization operates a portfolio of advocacy programs rather than a unified product: the Rare Cancer Policy Coalition (RCPC) for rare cancer reimbursement issues, Health Equity in Access to Treatments (HEAT) for disparities in underserved communities, ROPE BRIDGE for payer engagement, and Patient-Oriented Value (POV©) reports that translate patient perspectives into value framework inputs. It runs a Speaker Series featuring FDA, CMS, and industry officials, and conducts direct congressional engagement including hosting roundtables with Senate HELP & Finance Committees and the Congressional Rare Caucus.

The organization's core recent activities center on legislative and regulatory advocacy: it successfully shepherded HEART Act provisions into the 2022 FDA user fee package, filed a Petition for Rulemaking with the FDA in April 2026 calling for a legally binding context-based evidence framework, and drove bipartisan introduction of the PROTECT Rare Act (S.3551) in the Senate. Haystack Project is funded through donations and contributions from individuals, foundations, and industry partners; participation in the coalition is free for qualifying patient advocacy organizations. The organization is staffed by a small team of 6 employees and operates exclusively within the United States.

Haystack Project firmographics

Firmographics
Name
Haystack Project
Legal name
The Haystack Project
Website
https://haystackproject.org
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
Haystack Project is a 501(c)(3) nonprofit coalition founded in 2016 that unites 140+ ultra-rare disease patient advocacy organizations to advocate for systemic improvements in healthcare access, FDA regulatory frameworks, payer engagement, and health equity through legislative advocacy, policy initiatives, and educational programming in the United States.
Ownership category
akta.pro rank

Haystack Project industry classification

Industry
Product category
Rare Disease Patient Advocacy
NAICS
Voluntary Health Organizations (813212), Individual and Family Services (6241)
SIC
Services-Social Services (8300), Services-Membership Organizations (8600)
akta.pro industry
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYHLAJAKAN
Global Health Research, Evidence & Technical Assistance Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)

Keywords

  • Rare disease advocacy
  • Patient advocacy coalition
  • Ultra-rare diseases
  • Healthcare policy advocacy
  • Patient access programs

Haystack Project business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Donations and Contributions: As a 501(c)(3) nonprofit organization, Haystack Project likely relies on tax-deductible donations from individuals, foundations, and industry partners to fund its operations and advocacy programs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Haystack Project product offering

Product offering

Core offering

Haystack Project is a 501(c)(3) non-profit coalition that brings together 140+ ultra-rare disease patient advocacy organizations to address systemic obstacles to patient access. The organization educates policymakers and payers, develops patient-oriented value frameworks, and engages in legislative and regulatory advocacy (including FDA petitions and acts like PROTECT Rare and HEART) to evolve healthcare payment and delivery systems for rare disease therapies.

Product overview

Haystack Project is a non-profit 501(c)(3) coalition of over 140 ultra-rare patient groups that does not offer a unified software product but rather operates a portfolio of advocacy programs and initiatives. The organization connects rare disease patient advocacy organizations to address systemic patient access obstacles through educational outreach, legislative advocacy (PROTECT Rare Act, HEART Act), payer engagement (ROPE BRIDGE), health equity initiatives (HEAT), patient-oriented value assessment frameworks (POV© Reports), and the Rare Cancer Policy Coalition. Key activities include submitting policy petitions to the FDA (Context-Based Evidence Framework), hosting speaker series, producing white papers and reports, and engaging in coalition-building with stakeholders across the healthcare system.

Differentiator

Problem solved

Functional benefit

Brands

  • Rare Cancer Policy Coalition (RCPC): A Haystack Project initiative that brings together rare cancer patient organizations focusing on systemic reimbursement barriers and emerging landscape changes impacting new product development and treatment access for rare cancer patients.
  • Health Equity in Access to Treatments (HEAT)
  • Patient-Oriented Value (POV)
  • ROPE BRIDGE

Quantifiable outcome

  • Petition for Rulemaking submitted to FDA calling for context-based evidence framework for rare disease therapies
  • +2 more outcomes

Companies that use Haystack Project

Customer profile

Named customers2 records

Segments1 record

Ideal customer profiles2 records

Haystack Project technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Haystack Project partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Rare Cancer Policy Coalition (RCPC)coreStrategic or Co-development PartnerRCPC is a Haystack Project initiative bringing together rare cancer patient organizations. It is the only rare cancer coalition focused specifically on reimbursement, access and value issues. Working within Haystack enables RCPC participants to leverage synergies and common goals to optimize advocacy in disease states where unmet need is high and treatment inadequacies can be catastrophic. National Cancer Institute defines rare cancer as occurring in fewer than 15 out of 100,000 people per year.
  • Siegel Rare Neuroimmune Association (SRNA)coreStrategic or Co-development PartnerSRNA is the first organization to leverage Haystack Project's Health Equity in Access to Treatments (HEAT) initiative. The partnership aims to investigate health equity issues in neuroimmune disorders, understand variability in access and disease burden, identify barriers to diagnosis and treatment especially for underserved populations, and assess representativeness of SRNA's outreach and education efforts.
  • ROPE BRIDGE Payer Council PartnerscoreStrategic or Co-development PartnerHaystack Project is launching ROPE BRIDGE, a collaborative bi-directional education effort with payers including Medicare Advantage plans, Medicaid managed care plans, and other community, regional, and national plans. The initiative seeks common ground between payers and patients, creating ongoing dialogue about utilization management approaches, documentation requirements, and medical necessity criteria.
  • Institute for Clinical and Economic Review (ICER)coreStrategic or Co-development PartnerHaystack Project has engaged extensively with ICER's stakeholder engagement function and secured access to ICER's Analytics and modeling capabilities. Haystack joined ICER's Fair Access Working Group. The organization has spent considerable time educating 80+ rare patient groups about value frameworks and their impact on patient access, and the inadequacy of models used by ICER for extremely rare conditions.
  • American Enterprise Institute (AEI)minorGTM or Marketing PartnerAEI logo appears on the Speaker Series page, indicating a partnership for educational programming. Nature of partnership appears to involve joint hosting of speaker series events or educational content related to healthcare policy.
  • Alliance of Community Health PlansminorStrategic or Co-development PartnerOrganization represented in Haystack Project speaker series, indicating ongoing dialogue on rare disease policy issues. Nissa Shaffi, Associate Director of Public Policy, presented at October 2023 speaker series.

Scale indicators1 record

Recent moves6 records

Expansion highlights6 records

Haystack Project competitors and assessment

Company assessment

Direct peers

  • Patient Advocate Foundation: Patient Advocate Foundation provides direct case management and access support for patients including those with rare diseases; comparable in patient access mission and payer navigation focus, though service-delivery rather than coalition-based.
  • Global Genes: Global Genes is a rare disease patient advocacy organization that builds coalitions, educates patients, and advocates for policy; it is directly comparable to Haystack in mission and constituency, though with broader (rather than ultra-rare) disease coverage.
  • National Patient Advocate Foundation: National Patient Advocate Foundation provides case management, policy advocacy, and financial assistance for patients with chronic and rare diseases; it is comparable to Haystack's patient advocacy and payer engagement focus.
  • Rare Disease Legislative Advocates (RDLA): RDLA coordinates Congressional advocacy for the rare disease community, including Rare Disease Week on Capitol Hill—an activity that directly overlaps with Haystack's Congressional engagement and Protect Rare Act advocacy.
  • EveryLife Foundation for Rare Diseases: EveryLife Foundation is a rare disease public policy advocacy organization that drives federal and state policy on newborn screening, access to therapies, and FDA engagement—directly comparable to Haystack's legislative and regulatory advocacy mission.

Others

  • FasterCures (Milken Institute): FasterCures is a policy and advocacy program of the Milken Institute focused on accelerating medical research and patient access; it is adjacent to Haystack in the rare disease policy ecosystem but operates from a think-tank rather than coalition structure.

Broad incumbents

  • National Organization for Rare Disorders (NORD): NORD is the largest US rare disease patient advocacy organization representing 300+ disease-specific member organizations; it is a broad incumbent in the same space as Haystack, with deeper resources but broader (rather than ultra-rare-focused) policy agenda.
  • National Health Council: National Health Council is a membership organization for patient advocacy groups that engages on value assessment, payer access, and FDA policy; comparable to Haystack as an umbrella advocacy coalition, though broader than ultra-rare.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Haystack Project social profiles

Digital presence

Haystack Project financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Haystack Project leadership team

Management profile

Number of profiles

Profiles1 record

Haystack Project funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Haystack Project M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Haystack Project

What does Haystack Project do?

Haystack Project is a 501(c)(3) non-profit coalition that brings together 140+ ultra-rare disease patient advocacy organizations to address systemic obstacles to patient access. The organization educates policymakers and payers, develops patient-oriented value frameworks, and engages in legislative and regulatory advocacy (including FDA petitions and acts like PROTECT Rare and HEART) to evolve healthcare payment and delivery systems for rare disease therapies.

Is Haystack Project a public or private company?

Haystack Project is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Haystack Project founded?

Haystack Project was founded in 2016. It employs 1 to 10 people.

How does Haystack Project make money?

One revenue line is on record: donations and Contributions.

Who are Haystack Project's main competitors?

Direct peers on record are Patient Advocate Foundation, Global Genes, National Patient Advocate Foundation, Rare Disease Legislative Advocates (RDLA) and EveryLife Foundation for Rare Diseases. FasterCures (Milken Institute) is listed as an others. Broad incumbents are National Organization for Rare Disorders (NORD) and National Health Council.

Does Haystack Project have an API?

No public API is recorded for Haystack Project.

What industry is Haystack Project in?

Haystack Project's product category is Rare Disease Patient Advocacy. Its primary akta.pro industry code is BPAGACAM, Rare Disease & Special Needs Support Organizations, with a secondary code of HLAJAKAN, Global Health Research, Evidence & Technical Assistance Organizations. Its NAICS code is 813212 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals